Benjamin Spink

1.1k total citations
9 papers, 842 citations indexed

About

Benjamin Spink is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Benjamin Spink has authored 9 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Benjamin Spink's work include Pancreatic function and diabetes (2 papers), Cardiomyopathy and Myosin Studies (2 papers) and Cellular Mechanics and Interactions (2 papers). Benjamin Spink is often cited by papers focused on Pancreatic function and diabetes (2 papers), Cardiomyopathy and Myosin Studies (2 papers) and Cellular Mechanics and Interactions (2 papers). Benjamin Spink collaborates with scholars based in United States, Netherlands and South Korea. Benjamin Spink's co-authors include James A. Spudich, Volker Schellenberger, Willem P.C. Stemmer, Sebastian Doniach, Sivaraj Sivaramakrishnan, Jeffrey L. Cleland, Chia‐Wei Wang, Michael D. Scholle, Yi Yao and Yong Yin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Molecular Cell.

In The Last Decade

Benjamin Spink

8 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Spink United States 8 526 173 158 122 90 9 842
Philippe Cuniasse France 19 625 1.2× 49 0.3× 98 0.6× 21 0.2× 147 1.6× 31 968
Alessandro Mascioni United States 15 535 1.0× 109 0.6× 103 0.7× 43 0.4× 105 1.2× 29 892
Aaron P. Yamniuk United States 18 647 1.2× 166 1.0× 39 0.2× 99 0.8× 140 1.6× 40 1.1k
Yoshito Numata Japan 23 627 1.2× 239 1.4× 43 0.3× 106 0.9× 87 1.0× 46 1.2k
Vincent Mikol France 23 1.1k 2.0× 118 0.7× 47 0.3× 115 0.9× 261 2.9× 37 1.6k
Rui Kamada Japan 17 471 0.9× 25 0.1× 109 0.7× 30 0.2× 208 2.3× 69 1.1k
Steven W. Millward United States 20 855 1.6× 356 2.1× 33 0.2× 35 0.3× 135 1.5× 48 1.3k
Mary Struthers United States 15 576 1.1× 66 0.4× 21 0.1× 36 0.3× 195 2.2× 30 1.0k
Marco Cavalli Sweden 15 699 1.3× 36 0.2× 25 0.2× 62 0.5× 47 0.5× 33 956
Tom Wu United States 16 606 1.2× 60 0.3× 19 0.1× 37 0.3× 95 1.1× 27 1.1k

Countries citing papers authored by Benjamin Spink

Since Specialization
Citations

This map shows the geographic impact of Benjamin Spink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Spink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Spink more than expected).

Fields of papers citing papers by Benjamin Spink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Spink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Spink. The network helps show where Benjamin Spink may publish in the future.

Co-authorship network of co-authors of Benjamin Spink

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Spink. A scholar is included among the top collaborators of Benjamin Spink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Spink. Benjamin Spink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Cleland, Jeffrey L., Jerome A. Moore, Benjamin Spink, et al.. (2012). A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life. Journal of Pharmaceutical Sciences. 101(8). 2744–2754. 57 indexed citations
3.
Alters, Susan E., Benjamin Spink, Chia‐Wei Wang, et al.. (2012). GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn’s Disease Model. PLoS ONE. 7(11). e50630–e50630. 53 indexed citations
4.
To, Wayne, Benjamin Spink, Michael D. Scholle, et al.. (2010). Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose. PLoS ONE. 5(4). e10175–e10175. 40 indexed citations
5.
Schellenberger, Volker, Chia‐Wei Wang, Benjamin Spink, et al.. (2009). A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner. Nature Biotechnology. 27(12). 1186–1190. 340 indexed citations
6.
Spink, Benjamin, Sivaraj Sivaramakrishnan, Jan Lipfert, Sebastian Doniach, & James A. Spudich. (2008). Long single α-helical tail domains bridge the gap between structure and function of myosin VI. Nature Structural & Molecular Biology. 15(6). 591–597. 97 indexed citations
7.
Sivaramakrishnan, Sivaraj, Benjamin Spink, Adelene Y. L. Sim, Sebastian Doniach, & James A. Spudich. (2008). Dynamic charge interactions create surprising rigidity in the ER/K α-helical protein motif. Proceedings of the National Academy of Sciences. 105(36). 13356–13361. 89 indexed citations
8.
Rock, Ronald S., Bhagavathi Ramamurthy, Alexander R. Dunn, et al.. (2005). A Flexible Domain Is Essential for the Large Step Size and Processivity of Myosin VI. Molecular Cell. 17(4). 603–609. 80 indexed citations
9.
Brzezinski, Monica R., Benjamin Spink, Ralph A. Dean, et al.. (1997). Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.. PubMed. 25(9). 1089–96. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Cuniasse Breakdown of academic impact, for papers by Alessandro Mascioni Breakdown of academic impact, for papers by Aaron P. Yamniuk Breakdown of academic impact, for papers by Yoshito Numata Breakdown of academic impact, for papers by Vincent Mikol Breakdown of academic impact, for papers by Rui Kamada Breakdown of academic impact, for papers by Steven W. Millward Breakdown of academic impact, for papers by Mary Struthers Breakdown of academic impact, for papers by Marco Cavalli Breakdown of academic impact, for papers by Tom Wu
Rankless by CCL
2026